About ARMR Systems
ARMR Systems develops wearable hemorrhage control systems. It increases the survivability of traumatic battlefield injuries where advanced medical support is not immediately available. Its integrated solutions provide warfighters, combat medics, and other field-based personnel with lifesaving trauma care capabilities unmatched in battlefield environments. It was formerly known as Traumedex. The company was founded in 2014 and is based in Baltimore, Maryland.
Latest ARMR Systems News
Sep 15, 2023
Weekly Quick Hits (BHCR) – Week of September 11, 2023 Baltimore shot to the top of the charts of a new national ranking of underdog life science hubs this week, showing the country what regional ecosystem members already know–that the life science community is coalescing and growing in amplified, shared value. The regional ripple effect continues, with activity from the D.C. sphere and out to Frederick joining multiple public and private institutions in active collaborations. As innovation activity and regulatory stimuli come from places like Johns Hopkins and CDC, researchers and business leaders are teaming up to expedite delivery of leading solutions to patients, not least with a new wave of COVID vaccines. By Sam Hopkins | September 15, 2023 Quick Hits is BioBuzz’s weekly round up of all the life science news you don’t want to miss, in your region of interest. Don’t miss a beat; SUBSCRIBE to our weekly Quick Hits newsletter via LinkedIn ( BioHealth Capital Region , Greater Philadelphia , Research Triangle Park) or get it delivered to your inbox every week. Funding, Awards and Collaborations Baltimore makes list of 9 North American Cities Emerging as Life Science Hubs Drug Discovery & Development gave Charm City its highest score in the ranking of non-traditional cities moving life sciences into the future, separate from Boston and San Francisco. The spotlight on Baltimore focused on the 38-member consortium led by the Greater Baltimore Committee and included many local universities including Morgan State, Coppin State, Johns Hopkins, and the University of Maryland with its BioPark , and points to its strong cell and gene therapy sectors and recent leading role in advancing COVID-19 vaccine development and manufacturing. TEDCO Invests in ARMR Systems Hemorrhage Control Tech Baltimore’s ARMR Systems asks, “what if every soldier could be a medic?” TEDCO, through its Social Impact Builder Funds, wants to advance the company’s investigation and development of solutions for field trauma in military operations, investing $250,000. CEO Chibueze Ihenacho says, “90% of preventable military deaths are due to hemorrhage, with 1 out of 4 being caused by non-compressible injuries that are not amenable to traditional tourniquets.” This isn’t the first TEDCO investment for ARMR , which has already drawn from TEDCO’s Seed Fund and its Rural and Underserved Business Recovery from Impact of COVID-19 (RUBRIC) program. JHTV Releases Annual Report for FY 2023 Johns Hopkins Technology Ventures (JHTV), the technology transfer arm of Johns Hopkins University responsible for interfacing with researchers at the world-renowned institution and working with industry to bring their innovations to the world, released its annual report highlighting several accomplishments, including: More than $44 million in licensing revenue and collaborations with 39 corporate research sponsors Greater than $550 million raised in venture funding achieved by 20 startups connected to the university $2.2 million in translational funding awards In the report, Christy Wyskiel, Sr. Advisor to the President of JHU for Innovation and Entrepreneurship and Executive Director of JHTV, cited the example of retired U.S. Army Gen. Stanley McChrystal for inspiring the tech transfer office and its teams to be flexible, communicate with low friction, and make efficient data-driven decisions. 8th Annual BHCR Crab Trap Selects 5 Finalists Startup life science and biotech companies from around the region and the world were named ahead of the September 20 BioHealth Capital Region Forum. Ranging from technology for removing cholesterol in tissues based in Washington, D.C., to a Tel Aviv-based maker of wearable eye-tracking AI technology for patients who are unable to speak, the finalists are up for more than $50,000 in total prizes and recognition. BioBuzz recently caught up with the winners of the 2022 Crab Trap winners to track their progress since last year’s competition . BioBuzz to Host Panel at Baltimore Together Summit BioBuzz will host a breakout session titled Serving the Needs of an Untapped Workforce at the 2nd Annual Baltimore Together Summit on October 30. If you’re a vested stakeholder in Baltimore and interested in building a stronger, more connected life science community here, or if you’re learning about how to position yourself to attract attention from forward-thinking organizations, sign up at the link below! The panel discussion will focus on: empowering individuals through new opportunities, and enlightening employers on meaningful engagement with an often-overlooked demographic American Gene Technologies Honored as Top Workplace in Bethesda Magazine AGT has the happiest employees in the Bethesda area, says the Best Companies Group in its MoCo360 feature in Bethesda Magazine . Based in Rockville, American Gene Technologies has 36 employees, all locally based. AGT recently spun off a new company called Addimmune , which is focused on curing HIV. In the Clinic BioFactura Publishes Phase 1 Clinical Study for its Stelara Biosimilar Frederick’s BioFactura, Inc. announced the publication of the phase 1 study for its biosimilar Stelara (ustekinumab) candidate, as published in Clinical Pharmacology in Drug Development . BioFactura, led by Chief Medical Officer and board chairman Jeffrey Hausfeld, MD, MBA, focuses on lower-priced biosimilar products, in this case using its StableFast Biomanufacturing Platform to meet bioequivalence criteria for Stelara, an immunosuppressive drug that can treat plaque psoriasis and psoriatic arthritis. The company announced in August that it had achieved a $33.5 million global commercialization deal for the Stelara biosimilar. New Products CDC and Advisory Committee Recommendation of 2023-2024 COVID-19 Vaccines to Boost Novavax Big global news came from the CDC on September 12, with its vote to recommend monovalent, XBB-containing vaccines for COVID-19 . This is expected to include Novavax’s XBB COVID vaccine. Gaithersburg-based Novavax focuses on the development of innovative vaccines and had previously announced its readiness for commercial delivery of the updated protein-bases non-mRNA COVID vaccine, to be widely available in the U.S., and the company is also working on authorizations with the European Medicines Agency and Health Canada. Research Roundup BullFrog AI to Partner with Baltimore’s Lieber Institute to Model Precision Brain Medicine Opportunities Gaithersburg’s BullFrog AI said this week that it would use its bfLEAP platform to mine comprehensive brain data at the Lieber Institute for Brain Development (LIBD), which has had its home in the Baltimore Johns Hopkins Bioscience Park since 2010. LIBD Director and CEO, Dr. Daniel Weinberger, said the collaboration would rapidly accelerate R&D. LIBD has the largest collection of postmortem brains in the world for the study of neuropsychiatric disorders, numbering over 4,000. The Lieber Institute for Brain Development is a member of the BMore Bio initiative . On the Hill – Regulatory and Advocacy Children’s National Shares Maternal Health Insights on Capitol Hill Dr. Lenore Jarvis, an affiliate faculty member of the Child Health Advocacy Institute at Children’s National Hospital in Washington, D.C., participated in a congressional briefing where she discussed the importance of screening caregivers for perinatal mood and anxiety disorders (PMADs). Dr. Jarvis and the panel focused on obstacles including stigmas around seeking care in communities of color and military populations. Children’s National screens for PMADs in primary care clinics as well as approaching caregivers in emergency departments and neonatal intensive care units (NICUs). Dr. Jarvis, who directs advocacy and health policy for the Children’s National Division of Emergency Medicine , added that long wait times and insurance coverage issues need to be addressed. After screening, social workers and other professionals can help address potential issues for those families experiencing PMADs, which are responsible for nearly one-quarter of all maternal deaths. Coming in October Maryland Tech Council Releases Agenda for Oct. 30 Bio Innovation Conference The conference , set to take place at the Bethesda North Marriott Hotel and Conference Center, is open to life science professionals and job seekers as well as companies looking to make connections with potential colleagues and clients. The agenda includes a keynote from Dr. Peter Marks of the FDA on Expediting the Development and Availability of Gene Therapy. About the Author
ARMR Systems Frequently Asked Questions (FAQ)
When was ARMR Systems founded?
ARMR Systems was founded in 2014.
Where is ARMR Systems's headquarters?
ARMR Systems's headquarters is located at 101 West Dickman Street, Baltimore.
What is ARMR Systems's latest funding round?
ARMR Systems's latest funding round is Seed VC.
How much did ARMR Systems raise?
ARMR Systems raised a total of $750K.
Who are the investors of ARMR Systems?
Investors of ARMR Systems include Tamiami Angel Fund, Maryland Momentum Fund, University of Maryland, DreamIt Securetech, Maryland Technology Development Corporation and 4 more.
Who are ARMR Systems's competitors?
Competitors of ARMR Systems include Frontline Medical and 4 more.
Compare ARMR Systems to Competitors
Prytime Medical is a medical device company that focuses on the design, development, and commercialization of minimally invasive solutions for hemorrhage control. The company's main product is a balloon catheter, which is used to temporarily block large blood vessels in order to control bleeding, particularly in emergency and critical care situations. The company's products are primarily used in the trauma sector, with increasing use in adjacent sectors such as cardiac arrest, postpartum hemorrhage, interventional radiology, and pre-hospital care. It was founded in 2014 and is based in Boerne, Texas.
Pneumeric develops novel visual detection devices intended to decompress tension pneumothorax. The company's portable device provides confirmatory color change offering a straightforward prehospital-based therapy. The company was founded in 2021 and is based in Rochester, Minnesota.
TyTek Medical is a manufacturer of compact, pre-hospital emergency medical supplies for trauma care in the medical equipment industry. The company offers products designed to provide emergency first aid and stabilize patients in critical situations. These supplies are engineered for military medics and are also utilized by various non-military first responders, including Search & Rescue, Fire/EMS, and Tactical EMS teams. It was founded in 2011 and is based in West Chester, Ohio.
Safeware is a company that specializes in public preparedness and safety, operating within the safety equipment and emergency preparedness industry. The company offers a wide range of products including protective clothing, emergency first aid kits, gas detection devices, and communication systems, all designed to ensure safety and preparedness in various situations. Safeware primarily serves sectors such as the industrial, government, military, and emergency response markets. It was founded in 1979 and is based in Lanham, Maryland.
Acuity International is a company that focuses on providing critical services to government and commercial enterprises, operating within sectors such as engineering, consulting, healthcare, and construction management. The company offers a range of services including occupational health services, disaster and emergency response, program and construction management, global security services, and base and critical facilities management. Acuity International primarily serves the government and commercial sectors. It was founded in 1975 and is based in Reston, Virginia.
Amphenol Fiber Systems International (AFSI) is a full service fiber optic company engaged in the fabrication and manufacture of fiber optic connectivity products and systems. The company's commitment to technical excellence aims to make us an industry leader in providing sophisticated products and professional technical assistance in the fiber optic industry. AFSI aims to provide solutions for communications systems based on fiber optic interconnect technology. TFOCA-II, M83522, M29504, and M28876 are the global standards in the military marketplace. With over 100 employees, AFSI is currently located in a 50,000 square foot facility, in the heart of the telecom corridor in Allen, just north of Dallas, Texas. Since its inception in 1993, AFSI has and will continue to base its corporate strategy on technical and application support, quality assurance, product performance, and value.